Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells.
about
CRISPR/Cas9-mediated gene editing in human tripronuclear zygotesSpermatogonial stem cell autotransplantation and germline genomic editing: a future cure for spermatogenic failure and prevention of transmission of genomic diseasesCustomizing the genome as therapy for the β-hemoglobinopathiesThe Rise of CRISPR/Cas for Genome Editing in Stem CellsLong-term dual-color tracking of genomic loci by modified sgRNAs of the CRISPR/Cas9 system.CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformationGenome editing: the road of CRISPR/Cas9 from bench to clinicEpigenetic Memory Underlies Cell-Autonomous Heterogeneous Behavior of Hematopoietic Stem CellsHuman Germline CRISPR-Cas Modification: Toward a Regulatory Framework.Applications of CRISPR-Cas9 mediated genome engineering.Regenerative medicine: targeted genome editing in vivo.Targeted Germline Modifications in Rats Using CRISPR/Cas9 and Spermatogonial Stem CellsGeneration of fertile offspring from Kit(w)/Kit(wv) mice through differentiation of gene corrected nuclear transfer embryonic stem cells.Efficient inversions and duplications of mammalian regulatory DNA elements and gene clusters by CRISPR/Cas9.CRISPR-Cas9-mediated genome editing and guide RNA design.Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.Dynamic Heterogeneity of Brachyury in Mouse Epiblast Stem Cells Mediates Distinct Response to Extrinsic Bone Morphogenetic Protein (BMP) Signaling.CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.Optimization of the production of knock-in alleles by CRISPR/Cas9 microinjection into the mouse zygote.CRISPR-Cas9: a new and promising player in gene therapy.Application of CRISPR/Cas9 genome editing to the study and treatment of disease.High-Throughput Silencing Using the CRISPR-Cas9 System: A Review of the Benefits and Challenges.CRISPR/Cas9 system: a powerful technology for in vivo and ex vivo gene therapy.Long-Term Propagation of Porcine Undifferentiated Spermatogonia.Plant-pathogen interactions: toward development of next-generation disease-resistant plants.Genome engineering through CRISPR/Cas9 technology in the human germline and pluripotent stem cells.The discovery and development of the CRISPR system in applications in genome manipulation.Modern Genome Editing Technologies in Huntington's Disease Research.Applications of CRISPR/Cas9 in retinal degenerative diseasesOverview of CRISPR-Cas9 Biology.Use of Stirred Suspension Bioreactors for Male Germ Cell Enrichment.Leapfrogging: primordial germ cell transplantation permits recovery of CRISPR/Cas9-induced mutations in essential genesTransfer of a Mouse Artificial Chromosome into Spermatogonial Stem Cells Generates Transchromosomic Mice.Genome Editing in Mouse Spermatogonial Stem Cell Lines Using TALEN and Double-Nicking CRISPR/Cas9.Sanofi-Cell Research outstanding paper award of 2015.Advances, challenges and future directions for stem cell therapy in amyotrophic lateral sclerosis.The Future of CRISPR Applications in the Lab, the Clinic and Society.CRISPR-Cas9-Mediated Gene Editing in Mouse Spermatogonial Stem Cells.The Potential of iPSCs for the Treatment of Premature Aging Disorders.Melatonin promotes development of haploid germ cells from early developing spermatogenic cells of Suffolk sheep under in vitro condition.
P2860
Q22337358-70C6538D-D7FD-4029-AB91-30BFA35700C8Q26744780-09F2A951-1F6C-44DA-B1FC-9F14FB8A9163Q26751061-F634F6A7-70B8-41C1-91B6-36DD5C0A769FQ26765852-1043F712-B0ED-4A50-A365-02BB143340C2Q27324149-2F916E99-B2DC-4180-B87F-5C78DA914AB9Q27339934-B5F47001-93F1-4C0B-98CD-5E55EF14A355Q28066970-9176E308-21C8-488F-9612-E01CEFE3C7D2Q33903937-27FDB98E-266C-4961-BA79-A11A69C2D768Q34503980-8880E076-2505-46A8-8340-6A8A81B7431FQ34669857-DA8AF13D-BB7D-4B72-B8CC-7406ADF825A4Q35146211-E0140736-93EC-416D-872E-89F0C58E660CQ35224542-CD0F44A4-BAC2-4A3F-BE84-C1237D74FEB4Q35823820-351AB7EF-09D5-46E8-912C-D6944CD0B622Q35914859-BAF31447-DF39-4E8E-9AD5-F7758D7B899DQ36149464-B67494A7-F4CA-4B78-9AC8-5F52F446CA11Q36910225-E00DE596-C36D-430F-BE88-E6DF23F9A848Q37098944-E38A661A-1711-41D9-9FDF-9395DB3DE1FDQ37559174-F761AEE9-FD3D-4B6D-AE03-9AC1D052B6FFQ37648801-48447544-BFD1-4888-AC0D-52B5FA21828BQ38364993-2E7BDCB4-0BF7-4CFA-B80F-B5D7EDC6AA88Q38397580-B4A85395-C147-4F37-961E-9347035E6952Q38498286-B8F6BEDA-51AE-44D7-B748-0541B2F7880DQ38680345-D238D25B-1C86-49F7-81E3-BA82E78D4158Q38687509-124665CD-175E-4570-966B-B956425685A4Q38706738-46163918-A6A3-4FB5-B227-12AEBEF95C08Q38757108-CA7FE8C3-8B9C-4F32-9D02-8910804B695BQ39095111-43BC7CCC-DFB5-4015-85F0-01D5DE0C79CBQ39106522-C77E2D9D-D067-4506-8C8E-A6AC7F265C4CQ39306038-4B60D6DD-7FED-48DD-9BC3-E06B6491DDA6Q40416750-51B2E569-8257-41D2-BED9-625A938E7564Q40973450-C23A005C-85CB-4E66-8E82-3111C75F4B85Q40975838-A3B9C9C3-75FE-43B1-AEAF-F66469C58299Q41931083-5FAADD2D-C017-42F0-9207-B7EB2FE17832Q42070255-0BBCAF63-51F9-4328-A114-F5F1C70570B3Q42736610-CC72D521-05C6-455B-A58C-38DEFC7EBF57Q44704967-EF736070-17BF-4E7E-821A-83691DFF0CCCQ46262974-7CE84134-6043-410C-94AD-164E4409979AQ46341003-DBB5386D-7875-444A-95EF-1ED8BCFFE3EDQ47105441-A73AC364-E6B1-4885-A2B5-2CE80897203DQ47879143-A8FCB583-1368-46C1-A3C0-35BB640E84A0
P2860
Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Correction of a genetic diseas ...... use spermatogonial stem cells.
@ast
Correction of a genetic diseas ...... use spermatogonial stem cells.
@en
Correction of a genetic diseas ...... use spermatogonial stem cells.
@nl
type
label
Correction of a genetic diseas ...... use spermatogonial stem cells.
@ast
Correction of a genetic diseas ...... use spermatogonial stem cells.
@en
Correction of a genetic diseas ...... use spermatogonial stem cells.
@nl
prefLabel
Correction of a genetic diseas ...... use spermatogonial stem cells.
@ast
Correction of a genetic diseas ...... use spermatogonial stem cells.
@en
Correction of a genetic diseas ...... use spermatogonial stem cells.
@nl
P2093
P2860
P356
P1433
P1476
Correction of a genetic diseas ...... use spermatogonial stem cells.
@en
P2093
Chikai Zhou
Chunlian Wu
Fuchou Tang
Hongshan Guo
Huijuan Shi
Jiaoyang Liao
Jinsong Li
P2860
P2888
P356
10.1038/CR.2014.160
P50
P577
2014-12-05T00:00:00Z